Search
Silence Therapeutics PLC
SLNAdd to Watchlist
13.550USD
-0.140-1.02%
Close 09-09 16:00（ET）
641.13MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-09-08The current earnings forecast score of Silence Therapeutics PLC is 8.00, ranking 168 out of 377 in the Biotechnology & Medical Research industry. The average price target is 30.00, with a high of 75.00 and a low of 4.00.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
35.800
Target Price
+145.37%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Silence Therapeutics PLC
SLN
7
Beigene Ltd
ONC
27
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
24
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Silence Therapeutics PLC's price target?
Analysts forecast that Silence Therapeutics PLC's price target is USD 30.00, with the highest forecast at USD 75.00 and the lowest forecast at USD 4.00.
What is the analyst rating for Silence Therapeutics PLC?
Based on the ratings of Silence Therapeutics PLC's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.